| |
| speakers |
| |
 |
chen xiaoxiang
vice president, medicine r&d, boehringer ingelheim china/hong kong/taiwan |
| |
 |
shen huaqiong
chief medical officer, jiangsu hengrui medicine co. ltd |
| |
 |
yu qin
legal specialist, r&d legal division, asia pacific, pfizer |
| |
 |
qiang shengzhen
site contract leader, parexel international |
| |
 |
li huafang
excutive director, chinaaro-p
pi, gcp platform, science and technology national major project for ind
director, mict, shanghai mental health center |
|
|
|
